Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
🙌 It's Here: the Only Stock Screener You'll Ever Need Get Started
Close

Genmab (GMAB)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
2,722.0 -13.0    -0.48%
- Closed. Currency in DKK ( Disclaimer )
Type:  Equity
Market:  Denmark
ISIN:  DK0010272202 
S/N:  65985932
  • Volume: 100,231
  • Bid/Ask: 0.0 / 0.0
  • Day's Range: 2,667.0 - 2,730.0
Genmab 2,722.0 -13.0 -0.48%

GMAB Cash Flow Statement

 
Featured here, the Cash Flow Statement for Genmab, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Cash Flow Statement
Collapse All
Period Ending: 2023
31/03
 2022
31/12
 2022
30/09
 2022
30/06
Period Length: 0 Months 0 Months 0 Months 0 Months
Net Income/Starting Line 226 584 2582 1891
Cash From Operating Activities 3235 398 1968 959
Depreciation/Depletion 21 275 22 16
Amortization - 70 - -
Deferred Taxes - - - -
Non-Cash Items 151 945 -361 -435
Cash Receipts - - - -
Cash Payments - - - -
Cash Taxes Paid 400 1128 - -
Cash Interest Paid 5 4 4 5
Changes in Working Capital 2837 -1476 -275 -513
Cash From Investing Activities -13 -136 -1382 -576
Capital Expenditures -104 -110 -82 -68
Other Investing Cash Flow Items, Total 91 -26 -1300 -508
Cash From Financing Activities -611 131 -642 -214
Financing Cash Flow Items - - - -
Total Cash Dividends Paid - - - -
Issuance (Retirement) of Stock, Net -590 157 -625 -200
Issuance (Retirement) of Debt, Net -21 -26 -17 -14
Foreign Exchange Effects -429 1034 1456 -
Net Change in Cash 2395 -484 561 745
Beginning Cash Balance 9893 10377 9816 9071
Ending Cash Balance 12288 9893 10377 9816
Free Cash Flow 2784.38 -2167.12 1113.12 498.38
Free Cash Flow Growth 228.48 -294.69 123.35 42.09
Free Cash Flow Yield 1.85 0.15 1.17 0.592
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the cash flow statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

GMAB Comments

Write your thoughts about Genmab
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mark Marriott
Mark Marriott Oct 27, 2021 7:48AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
this stock worths buying for the long term?
Reply
5 0
Report
The Note
TheNote Jul 26, 2021 11:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Target 3620 .. medium/long.Daily chart: https://invst.ly/vjgx1 Weekly chart: https://invst.ly/vjgxu
Reply
1 0
Report
The Note
TheNote Jul 26, 2021 11:33AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Cup with handle - emminent !!!https://www.proinvestor.com/boards/95471Translate from that site (from danish) into english.
Reply
0 0
Report
BaboonHunter Baloon
JohnJengaBaboons Mar 17, 2021 7:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
NBI might roll over. Risky now
Reply
0 0
Report
BaboonHunter Baloon
JohnJengaBaboons Mar 07, 2021 1:15PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
1992 indicative price vs 1901 close dk and 1970 close us
Reply
0 0
Report
BaboonHunter Baloon
JohnJengaBaboons Mar 07, 2021 1:15PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
2200 this week possible, imo
Reply
0 0
Report
BaboonHunter Baloon
JohnJengaBaboons Mar 04, 2021 5:31AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
nice correction - but have more or less only removed dec7jan baboon buys
Reply
0 0
Report
Martin Lynge
Martin Lynge Mar 04, 2021 5:31AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
You mean since June last year.. .. Giant sell out...
Reply
0 0
Report
Martin Lynge
Martin Lynge Jun 27, 2019 2:52PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
US 1st line approval this evening... 1200+ tomorrow?
Reply
2 0
Report
Michael Almskov
Michael Almskov Jun 27, 2019 2:10PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
https://oasm.finanstilsynet.dk/dk/vismeddelelse.aspx?aid=f7f1738b-beb1-47b2-a9dc-ab402ccd42e9
Reply
3 0
Report
Michael Almskov
Michael Almskov Jun 19, 2019 3:15PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Blackrock now owns 5% of the shares in genmab
Reply
4 0
Report
Martin Lynge
Martin Lynge Feb 25, 2019 9:08AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Interesting to see, if we go beyond 1120 this time...
Reply
1 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email